Top

Published in:

Open Access 01-12-2023 | Helicobacter Pylori | Research

Prevalence of Helicobacter pylori genotypes: cagA, vacA (m1), vacA (s1), babA2, dupA, iceA1, oipA and their association with gastrointestinal diseases. A cross-sectional study in Quito-Ecuador

Authors: Santiago Bustos-Fraga, Marco Salinas-Pinta, Yosselin Vicuña-Almeida, Ricardo Brandt de Oliveira, Lucy Baldeón-Rojas

Published in: BMC Gastroenterology | Issue 1/2023

Abstract

Background

The most prevalent stomach infection in the world is caused by Helicobacter pylori (H. pylori). Several pathogenicity genes, including cagA, vacA, babA2, dupA, iceA, and oipA, are associated with an increased risk of gastrointestinal disease such as peptic ulcer and stomach cancer. This research aims to determine the prevalence of different H. pylori genotypes and correlate their risk in the development of gastrointestinal diseases in the Ecuadorian population.

Methods

A cross-sectional research of 225 patients at the Calderón Hospital in Quito, Ecuador, was conducted. End point PCRs were run to determine the presence of 16S rRNA, cagA, vacA (m1), vacA (s1), babA2, dupA, iceA1, and oipA virulence genes. Chi-square test, odds ratios (OR) and 95% confidence intervals (CI) were utilized for the statistical analysis.

Results

H. pylori infection was present in 62.7% of people. Peptic ulcers were seen in 22.2% and malignant lesions in 3.6% of patients. Genes oipA (93.6%), vacA (s1) (70.9%), and babA2 (70.2%) were the most prevalent. cagA/vacA (s1m1) and cagA/oipA (s1m1) combinations were found in 31.2% and 22.7% of the cases, respectively. Acute inflammation has a significant correlation with the genes cagA (OR = 4.96 95% CI: 1.1–22.41), babA2 (OR = 2.78 95% CI: 1.06–7.3), and the cagA/oipA combination (OR = 4.78, 95% CI: 1.06–21.62). Follicular hyperplasia was associated with iceA1 (OR = 3.13; 95% CI: 1.2–8.16), babA2 (OR = 2.56; 95% CI: 1.14–5.77), cagA (OR = 2.19; 95% CI: 1.06–4.52), and the cagA/oipA combination (OR = 2.32, 95% CI: 1.12–4.84). The vacA (m1) and vacA (s1m1) genes were associated with gastric intestinal metaplasia (OR = 2.71 95% CI: 1.17–6.29) (OR = 2.33 95% CI: 1.03–5.24). Finally, we showed that cagA/vacA (s1m1) gene combination increased the risk of duodenal ulcer development (OR = 2.89, 95% CI 1.10–7.58).

Conclusion

This study makes a significant contribution by offering genotypic information regarding H. pylori infection. The presence of several H. pylori genes was associated with the onset of gastrointestinal illness in the Ecuadorian population.

Hooi JKY, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9. https://doi.org/10.1053/j.gastro.2017.04.022.CrossRefPubMed

Curado MP, de Oliveira MM, de Araújo Fagundes M. Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: a systematic review and meta-analysis. Cancer Epidemiol. 2019;60:141–8.CrossRefPubMed

Amieva M, Peek RM. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150(1):64–78. https://doi.org/10.1053/J.GASTRO.2015.09.004.CrossRefPubMed

Abadi AT, Ierardi E, Lee YY. Why do we still have Helicobacter Pylori in our Stomachs. Malays J Med Sci. 2015;22(5):70–5.PubMedPubMedCentral

Hussain SA, Hamid S. Helicobacter pylori in humans: where are we now? Adv Biomed Res. 2014;3(1):63. https://doi.org/10.4103/2277-9175.125844.CrossRefPubMedPubMedCentral

Falush D, et al. Traces of human migrations in Helicobacter pylori populations. Science (80- ). 2003;299(5612):1582–5. https://doi.org/10.1126/science.1080857.CrossRef

Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol. 2022;53(1):33–50. https://doi.org/10.1007/S42770-021-00675-0.CrossRefPubMedPubMedCentral

Hayashi Y, et al. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 2013;62(11):1536–46. https://doi.org/10.1136/gutjnl-2011-301625.CrossRefPubMed

Takahashi-Kanemitsu A, Knight CT, Hatakeyama M. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cell Mol Immunol. 2020;17(1):50–63. https://doi.org/10.1038/S41423-019-0339-5.CrossRefPubMed

10.

Kim IJ, Blanke SR. Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front Cell Infect Microbiol. 2012;2:37. https://doi.org/10.3389/FCIMB.2012.00037.CrossRefPubMedPubMedCentral

11.

Ricci. “Relationship between VacA toxin and host cell autophagy in Helicobacter pylori infection of the human stomach: a few answers, many questions,.” Toxins (Basel). 2016;8(7):203.CrossRefPubMed

12.

Roy R, Jonniya NA, Sk MF, Kar P. Comparative structural dynamics of isoforms of Helicobacter pylori adhesin baba bound to lewis b hexasaccharide via multiple replica molecular dynamics simulations. Front Mol Biosci. 2022;9:852895.CrossRefPubMedPubMedCentral

13.

Ansari S, Yamaoka Y. Helicobacter pylori BabA in adaptation for gastric colonization. World J Gastroenterol. 2017;23(23):4158–69. https://doi.org/10.3748/wjg.v23.i23.4158.CrossRefPubMedPubMedCentral

14.

Abadi ATB, Perez-Perez G. Role of dupA in virulence of Helicobacter pylori. World J Gastroenterol. 2016;22(46):10118–23. https://doi.org/10.3748/wjg.v22.i46.10118.CrossRef

15.

Abu-Taleb AMF, et al. Prevalence of Helicobacter pylori cagA and iceA genes and their association with gastrointestinal diseases. Int J Microbiol. 2018;2018:4809093. https://doi.org/10.1155/2018/4809093.CrossRefPubMedPubMedCentral

16.

Matsuo Y, Kido Y, Yamaoka Y. Helicobacter pylori outer membrane protein-related pathogenesis. Toxins (Basel). 2017;9(3):101. https://doi.org/10.3390/TOXINS9030101.CrossRefPubMed

17.

Carrera S, Llumiquinga R. Registro Estadístico de Defunciones Generales INEC JUNIO 2020. Instituto Nacional de Estadística y Censos. 2020. https://www.ecuadorencifras.gob.ec. Accessed 14 June 2022.

18.

Dixon MF, et al. Classification and grading of gastritis. the updated Sydney system. international workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161–81. https://doi.org/10.1097/00000478-199610000-00001.CrossRefPubMed

19.

Valenzuela S. Estudio epidemiológico en la población ecuatoriana de los factores de riesgo asociados a la infección con Helicobacter pylori. Repositorio Digital USFQ. 2016. https://repositorio.usfq.edu.ec/handle/23000/5905. Accessed 20 May 2020.

20.

Chattopadhyay S, et al. Multiplex PCR assay for rapid detection and genotyping of Helicobacter pylori directly from biopsy specimens. J Clin Microbiol. 2004;42(6):2821–4. https://doi.org/10.1128/JCM.42.6.2821-2824.2004.CrossRefPubMedPubMedCentral

21.

Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of helicobacter pylori. association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995;270(30):17771–7. https://doi.org/10.1074/jbc.270.30.17771.CrossRefPubMed

22.

Delgado F. Comparación de genes de virulencia entre Helicobacter pylori y otras especies de Helicobacter en pacientes Ecuatorianos. Repositorio Digital USFQ. 2018. https://repositorio.usfq.edu.ec/handle/23000/7987. Accessed 20 May 2020.

23.

Torres K, Valderrama E, Sayegh M, Ramírez JL, Chiurillo MA. Study of the oipA genetic diversity and EPIYA motif patterns in cagA-positive Helicobacter pylori strains from Venezuelan patients with chronic gastritis. Microb Pathog. 2014;76:26–32. https://doi.org/10.1016/j.micpath.2014.09.006.CrossRefPubMed

24.

Bordin DS, Voynovan IN, Andreev DN, Maev IV. Current Helicobacter pylori diagnostics. Diagnostics. 2021;11(8):1458. https://doi.org/10.3390/DIAGNOSTICS11081458.CrossRefPubMedPubMedCentral

25.

Reyes Chacón J. A., et al. “Susceptibilidad antibiótica de Helicobacter pylori: un estudio de prevalencia en pacientes con dispepsia en Quito-Ecuador,.” Rev Colomb Gastroenterol. 2017;32(4):305.CrossRef

26.

Vázquez P. Prevalencia por infección por Helicobacter pylori y asociación con patalogías gástricas en pacientes adultos de chequeo ejecutivo desde enero del 2010 hasta septiembre del 2012 del Hospital Metropolitano de Quito-Ecuador. 2013. https://repositorio.usfq.edu.ec/handle/23000/1503. Accessed 22 Oct 2022.

27.

Bastos J, et al. Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults. Helicobacter. 2013;18(6):413–22. https://doi.org/10.1111/HEL.12061.CrossRefPubMed

28.

Ren S, et al. Prevalence of Helicobacter pylori infection in China: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37(3):464–70. https://doi.org/10.1111/JGH.15751.CrossRefPubMed

29.

Konturek PC, Kania J, Konturek JW, Nikiforuk A, Konturek SJ, Hahn EGH. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. Med Sci Monit. 2003;9(7):SR53–66.

30.

Azer S, Akhondi H. Gastritis. StatPearls. 2022. https://www.ncbi.nlm.nih.gov/books/NBK544250/. Accessed 17 June 2022.

31.

Montes P, Salazar S, Monge E. Cambios en la Epidemiologia de la Úlcera Péptica y su Relación con la Infección con Helicobacter Pylori. Hospital Daniel Carrion 2000–2005. 2007;27(4):382–388.

32.

Lin S, et al. Association of dietary patterns and endoscopic gastric mucosal atrophy in an adult Chinese population. Sci Rep. 2019;9(1):16567. https://doi.org/10.1038/S41598-019-52951-7.CrossRefPubMedPubMedCentral

33.

Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GNJ. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut. 1992;33(5):597–600. https://doi.org/10.1136/GUT.33.5.597.CrossRefPubMedPubMedCentral

34.

Bashiri H, Esmaeilzadeh A, Vossoughinia H, Ghaffarzadegan K, Raziei HR, Bozorgomid A. Association between gastric lymphoid follicles (Precursor of malt lymphomas) and h. pylori infection at a referral hospital in Iran. Clin Exp Gastroenterol. 2019;12:409–13. https://doi.org/10.2147/CEG.S224823.CrossRefPubMedPubMedCentral

35.

Holcombe C. Helicobacter pylori: the African enigma. Gut. 1992;33(4):429–31. https://doi.org/10.1136/GUT.33.4.429.CrossRefPubMedPubMedCentral

36.

Feliciano O, et al. Prevalence of Helicobacter pylori vacA, cagA, and iceA Genotypes in Cuban patients with upper gastrointestinal diseases. Biomed Res Int. 2015;2015:753710.CrossRefPubMedPubMedCentral

37.

Shetty V, Lingadakai R, Pai GC, Ballal M. Profile of Helicobacter pylori cagA & vacA genotypes and its association with the spectrum of gastroduodenal disease. Indian J Med Microbiol. 2021;39(4):495–9. https://doi.org/10.1016/j.ijmmb.2021.06.001.CrossRefPubMed

38.

Matos JI, De Sousa HAC, Marcos-Pinto R, Dinis-Ribeiro M. Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis. Eur J Gastroenterol Hepatol. 2013;25(12):1431–41. https://doi.org/10.1097/MEG.0b013e328364b53e.CrossRefPubMed

39.

Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE. Epidemiology of Helicobacter pylori and CagA-positive infections and global variations in gastric cancer. Toxins (Basel). 2018;10(4):163. https://doi.org/10.3390/TOXINS10040163.CrossRefPubMed

40.

Konráðsson A, Andersen L, Oddsson E, Guðjónsson H, Thornjóðleifsson B. Prevalence of Helicobacter pylori and Cag-A strains in patients with duodenal ulcer in Iceland. Laeknabladid. 2003;89(7–8):595–7.PubMed

41.

Ghose C, Perez-Perez GI, Van Doorn LJ, Domínguez-Bello MG, Blaser MJ. High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects. J Clin Microbiol. 2005;43(6):2635–41. https://doi.org/10.1128/JCM.43.6.2635-2641.2005.CrossRefPubMedPubMedCentral

42.

Pereira WN, et al. Association among H. pylori virulence markers dupA, cagA and vacAin Brazilian patients. J Venom Anim Toxins Incl Trop Dis. 2014;20(1):1. https://doi.org/10.1186/1678-9199-20-1/TABLES/2.CrossRefPubMedPubMedCentral

43.

Xu Q, Blaser MJ. Promoters of the CATG-specific methyltransferase gene hpyIM differ between iceA1 and iceA2 Helicobacter pylori strains. J Bacteriol. 2001;183(13):3875–84. https://doi.org/10.1128/JB.183.13.3875-3884.2001.CrossRefPubMedPubMedCentral

44.

Gatti LL, et al. Prevalence of Helicobacter pylori cagA, iceA and babA2 alleles in Brazilian patients with upper gastrointestinal diseases. Acta Trop. 2006;100(3):232–40. https://doi.org/10.1016/J.ACTATROPICA.2006.08.014.CrossRefPubMed

45.

Huang X, Deng Z, Zhang Q, Li W, Wang B, Li M. Relationship between the iceA gene of Helicobacter pylori and clinical outcomes. Ther Clin Risk Manag. 2016;12:1085–92. https://doi.org/10.2147/TCRM.S107991.CrossRefPubMedPubMedCentral

46.

Idowu A, et al. Detection of Helicobacter pylori and its virulence genes (cagA, dupA, and vacA) among patients with gastroduodenal diseases in Chris Hani Baragwanath Academic Hospital, South Africa. BMC Gastroenterol. 2019;19(1):73. https://doi.org/10.1186/S12876-019-0986-0.CrossRefPubMedPubMedCentral

47.

Argent R. H., Burette A, Miendje Deyi V. Y., Atherton J. C. “The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America,.” Clin Infect Dis. 2007;45(9):1204–6.CrossRefPubMed

48.

Dabiri H, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, oipA, iceA, babA2 and babB genotypes in Iranian dyspeptic patients. Microb Pathog. 2017;105:226–30. https://doi.org/10.1016/J.MICPATH.2017.02.018.CrossRefPubMed

49.

Chomvarin C, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis. 2008;12(1):30–6. https://doi.org/10.1016/J.IJID.2007.03.012.CrossRefPubMed

50.

Chen MY, He CY, Meng X, Yuan Y. Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer. World J Gastroenterol. 2013;19(26):4242–51. https://doi.org/10.3748/wjg.v19.i26.4242.CrossRefPubMedPubMedCentral

51.

Zhao Q, et al. Prevalence of Helicobacter pylori babA, oipA, sabA, and homB genes in isolates from Chinese patients with different gastroduodenal diseases. Med Microbiol Immunol. 2020;209(5):565–77. https://doi.org/10.1007/S00430-020-00666-2.CrossRefPubMed

52.

Yamaoka Y, Kikuchi S, ElZimaity HMT, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002;123(2):414–24. https://doi.org/10.1053/GAST.2002.34781.CrossRefPubMed

53.

Liu J, He C, Chen M, Wang Z, Xing C, Yuan Y. Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis. BMC Infect Dis. 2013;13:555. https://doi.org/10.1186/1471-2334-13-555.CrossRefPubMedPubMedCentral

Title: Prevalence of Helicobacter pylori genotypes: cagA, vacA (m1), vacA (s1), babA2, dupA, iceA1, oipA and their association with gastrointestinal diseases. A cross-sectional study in Quito-Ecuador
Authors: Santiago Bustos-Fraga
Marco Salinas-Pinta
Yosselin Vicuña-Almeida
Ricardo Brandt de Oliveira
Lucy Baldeón-Rojas
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Helicobacter Pylori
Polymerase Chain Reaction
Duodenal Ulcer
Published in: BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI: https://doi.org/10.1186/s12876-023-02838-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study

Magnetic-controlled capsule endoscopy performance in aging patients

Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R−/−mice

Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes

Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease

The effect of Trolox on the rabbit anal sphincterotomy repair

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage